FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer
Shah, Mirat, Osgood, Christy L, Amatya, Anup K, Fiero, Mallorie H, Pierce, William F, Nair, Abhilasha, Herz, Jonathan, Robertson, Kim J, Mixter, Bronwyn D, Tang, Shenghui, Pazdur, Richard, Beaver, Julia A, Amiri-Kordestani, Laleh
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer
Balasubramaniam, Sanjeeve, Beaver, Julia A, Horton, Sara, Fernandes, Laura L, Tang, Shenghui, Horne, Hisani N, Liu, Jinzhong, Liu, Chao, Schrieber, Sarah J, Yu, Jingyu, Song, Pengfei, Pierce, William, Robertson, Kim J, Palmby, Todd R, Chiu, Haw-Jyh, Lee, Eunice Y, Philip, Reena, Schuck, Robert, Charlab, Rosane, Banerjee, Anamitro, Chen, Xiao Hong, Wang, Xing, Goldberg, Kirsten B, Sridhara, Rajeshwari, Kim, Geoffrey, Pazdur, Richard
Published in Clinical cancer research (01.12.2017)
Published in Clinical cancer research (01.12.2017)
Get full text
Journal Article